Cart
sales@molnova.com
PI3K-IN-38
CAS No. 1382979-64-7
PI3K-IN-38( —— )
Catalog No. M35576 CAS No. 1382979-64-7
PI3K-IN-38 is an orally available and potent PI3K inhibitor with an IC50 value of 0.541 μM for PI3K-α. PI3K-IN-38 exhibits anticancer and anti-inflammatory activity and inhibits tumor growth in vivo.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 172 | In Stock |
|
| 10MG | 254 | In Stock |
|
| 25MG | 392 | In Stock |
|
| 50MG | 531 | In Stock |
|
| 100MG | 710 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePI3K-IN-38
-
NoteResearch use only, not for human use.
-
Brief DescriptionPI3K-IN-38 is an orally available and potent PI3K inhibitor with an IC50 value of 0.541 μM for PI3K-α. PI3K-IN-38 exhibits anticancer and anti-inflammatory activity and inhibits tumor growth in vivo.
-
DescriptionPI3K-IN-38 (compound 123) is an orally active PI3K inhibitor with IC50 of 0.541 μM (PI3K-α). PI3K-IN-38 shows activities of anticancer and anti-inflammatory, which inhibis tumor growth in vivo.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPI3K
-
RecptorPI3K
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1382979-64-7
-
Formula Weight380.44
-
Molecular FormulaC20H24N6O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1(C)C2=NC=3C(N2CCO1)=NC(=NC3N4CCOCC4)C5=CC=C(N)C=C5
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Dotson J, et al. Tricyclic pi3k inhibitor compounds and methods of use. WO2012082997A1.
molnova catalog
related products
-
GSK251
GSK251 is a highly potent, highly selective, orally bioavailable inhibitor of PI3Kδ with a novel binding mode.
-
mTOR inhibitor 9d
mTOR inhibitor 9d is a dual inhibitor of the protein kinases mTOR and PI3K with an mTOR IC50 value of 0.31 nm, and can be used for the treatment of leukemia, skin cancer, breast cancer, lung cancer and colon cancer.
-
GSK-2269557
GSK-2269557 is a highly potent and selective inhibitor of PI3Kδ (pKi=9.9).
